Effectiveness of Aripiprazole Long-acting Injection in Recent Onset and Chronic Schizophrenia Patients

Chonbuk National University

Status and phase

Completed

Phase 4

Conditions

Schizophrenia

Treatments

Drug: abilify maintena

Study type

Interventional

Funder types

Other

Industry

Identifiers

CUH 2018-02-011-005

Details and patient eligibility

About

The aim of the study is to investigate the effectiveness of Aripiprazole long-acting injection in recent onset and chronic schizophrenia patients

Full description

The aim of this study is to investigate the effectiveness of Aripiprazole long-acting injection in recent onset and chronic schizophrenia patients

Enrollment

82 patients

Sex

All

Ages

19 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patients diagnosed with schizophrenia according to DSM-5 diagnostic standards
men and women aged 19 and under 60
a person who is being given an atypical antipsychotic.
Patients should be able to reasonably cooperate with the questionnaire to be used for the study
a person who fully understands the purpose of the study and signs the consent
stable outpatient before screening without changing the volume of antipsychotics for at least two weeks

Exclusion criteria

a person who has a serious and unstable physical condition either now or in the past
A fertile woman who is currently pregnant or breastfeeding, or who is either unwilling or unable to use acceptable contraception until the clinical trial is complete.
a person suffering from severe drug allergies or complex and severe drug reactions
Patients who have taken clozapine in the last 60 days
subjects showing significant risk of suicide or significant risk of violent behavior based on past history or investigator's judgment